NCT01609400View on ClinicalTrials.gov

An Extension of CTN 31GB0607 to Evaluate Long Term Safety of NASHA Treatment in the Breast

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Breast Enhancement
Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT01609400 - An Extension of CTN 31GB0607 to Evaluate Long Term Safety of NASHA Treatment in the Breast | Biotech Hunter | Biotech Hunter